Avascular Necrosis of Hip
20
3
6
8
Key Insights
Highlights
Success Rate
73% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
15.0%
3 terminated out of 20 trials
72.7%
-13.8% vs benchmark
0%
0 trials in Phase 3/4
50%
4 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (20)
SCP Hip Outcomes Study
Observational Study to Evaluate Long-Term Outcome in Hip Hemiarthroplasty
Safety and Effectiveness of the HIT Reverse HRS
Exception Cementless Hip Stem
Avenir Complete Post-Market Clinical Follow-Up Study
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
Effect of Peri-operative Glucocorticoids on Short-term Functional Outcome After THA
Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment
Allofit® IT Ceramic Bearing System in Total Hip Arthroplasty
ROSA® Hip System THA PMCF
Metasul Monoblock Component™ Cup in a Hip Resurfacing Application With the Durom® Hip Resurfacing Femoral Component
A Comparison of Impingement Free Range of Motion With CT Scan After Manual and Robotic Total Hip Replacement
Role of Topical Vancomycin in Reducing Infections in Hip and Knee Arthroplasty
THA With and Without Computer Navigation
Maxera Large Cups - Canada
Post Market Clinical Follow-Up of the Zimmer Stafit Acetabular System
Survivorship and Patient Outcomes of Primary Total Hip Arthroplasty With the Ovation Hip System
Revision Total Hip Replacement Arthroplasty and Hematologic Variables
Rotational Thromboelstometry (ROTEM) change_colloid_total Hip Replacement Arthroplasty
THRA_hematologic Variables